Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes
- Author
- WANDALL, Hans H1 ; BLIXT, Ola1 ; BURCHELL, Joy4 ; CLAUSEN, Henrik1 ; TARP, Mads A1 ; PEDERSEN, Johannes W1 ; BENNETT, Eric P1 ; MANDEL, Ulla1 ; RAGUPATHI, Govind2 ; LIVINGSTON, Phil O2 ; HOLLINGSWORTH, Michael A3 ; TAYLOR-PAPADIMITRIOU, Joyce4
[1] Center for Glycomics, Departments of Cellular and Molecular Medicine and Oral Diagnostics, University of Copenhagen, Copenhagen, Denmark
[2] Department of Medicine, Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center, New York, New York, United States
[3] Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska, Omaha, Nebraska, United States
[4] King's College School of Medicine, Guy's Hospital London, London, United Kingdom - Source
Cancer research (Chicago, Ill.). 2010, Vol 70, Num 4, pp 1306-1313, 8 p ; ref : 49 ref
- CODEN
- CNREA8
- ISSN
- 0008-5472
- Scientific domain
- Medical oncology; Pharmacology drugs
- Publisher
- American Association for Cancer Research, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticorps Autoanticorps Autoimmunité Déterminant antigénique Glycopeptide Marqueur biologique Tumeur maligne Cancer Peptide
- Keyword (en)
- Antibody Autoantibody Autoimmunity Antigenic determinant Glycopeptide Biological marker Malignant tumor Cancer Peptides
- Keyword (es)
- Anticuerpo Autoanticuerpo Autoinmunidad Determinante antigénico Glicopéptido Marcador biológico Tumor maligno Cáncer Péptido
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents
- Discipline
- Pharmacological treatments Tumours
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 22486758
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1158/0008-5472.CAN-09-2893 
https://dx.doi.org/10.1158/0008-5472.CAN-09-2893
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-09-2893\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:4:\"1306\";s:8:\"\u0000*\u0000epage\";s:4:\"1313\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WANDALL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Hans H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"BLIXT, Ola\";i:1;s:13:\"BURCHELL, Joy\";i:2;s:15:\"CLAUSEN, Henrik\";i:3;s:12:\"TARP, Mads A\";i:4;s:20:\"PEDERSEN, Johannes W\";i:5;s:15:\"BENNETT, Eric P\";i:6;s:12:\"MANDEL, Ulla\";i:7;s:17:\"RAGUPATHI, Govind\";i:8;s:18:\"LIVINGSTON, Phil O\";i:9;s:24:\"HOLLINGSWORTH, Michael A\";i:10;s:27:\"TAYLOR-PAPADIMITRIOU, Joyce\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-09-2893\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:4:\"1306\";s:8:\"\u0000*\u0000epage\";s:4:\"1313\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WANDALL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Hans H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"BLIXT, Ola\";i:1;s:13:\"BURCHELL, Joy\";i:2;s:15:\"CLAUSEN, Henrik\";i:3;s:12:\"TARP, Mads A\";i:4;s:20:\"PEDERSEN, Johannes W\";i:5;s:15:\"BENNETT, Eric P\";i:6;s:12:\"MANDEL, Ulla\";i:7;s:17:\"RAGUPATHI, Govind\";i:8;s:18:\"LIVINGSTON, Phil O\";i:9;s:24:\"HOLLINGSWORTH, Michael A\";i:10;s:27:\"TAYLOR-PAPADIMITRIOU, Joyce\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-09-2893\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-09-2893\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:4:\"1306\";s:8:\"\u0000*\u0000epage\";s:4:\"1313\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WANDALL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Hans H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"BLIXT, Ola\";i:1;s:13:\"BURCHELL, Joy\";i:2;s:15:\"CLAUSEN, Henrik\";i:3;s:12:\"TARP, Mads A\";i:4;s:20:\"PEDERSEN, Johannes W\";i:5;s:15:\"BENNETT, Eric P\";i:6;s:12:\"MANDEL, Ulla\";i:7;s:17:\"RAGUPATHI, Govind\";i:8;s:18:\"LIVINGSTON, Phil O\";i:9;s:24:\"HOLLINGSWORTH, Michael A\";i:10;s:27:\"TAYLOR-PAPADIMITRIOU, Joyce\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-09-2893\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:4:\"1306\";s:8:\"\u0000*\u0000epage\";s:4:\"1313\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WANDALL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Hans H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"BLIXT, Ola\";i:1;s:13:\"BURCHELL, Joy\";i:2;s:15:\"CLAUSEN, Henrik\";i:3;s:12:\"TARP, Mads A\";i:4;s:20:\"PEDERSEN, Johannes W\";i:5;s:15:\"BENNETT, Eric P\";i:6;s:12:\"MANDEL, Ulla\";i:7;s:17:\"RAGUPATHI, Govind\";i:8;s:18:\"LIVINGSTON, Phil O\";i:9;s:24:\"HOLLINGSWORTH, Michael A\";i:10;s:27:\"TAYLOR-PAPADIMITRIOU, Joyce\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1158\/0008-5472.CAN-09-2893\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:9:\"\u0000*\u0000jtitle\";s:31:\"Cancer research (Chicago, Ill.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Cancer res. (Chic. Ill.)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:2:\"70\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:4:\"1306\";s:8:\"\u0000*\u0000epage\";s:4:\"1313\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-5472\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"WANDALL\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Hans H\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:10:\"BLIXT, Ola\";i:1;s:13:\"BURCHELL, Joy\";i:2;s:15:\"CLAUSEN, Henrik\";i:3;s:12:\"TARP, Mads A\";i:4;s:20:\"PEDERSEN, Johannes W\";i:5;s:15:\"BENNETT, Eric P\";i:6;s:12:\"MANDEL, Ulla\";i:7;s:17:\"RAGUPATHI, Govind\";i:8;s:18:\"LIVINGSTON, Phil O\";i:9;s:24:\"HOLLINGSWORTH, Michael A\";i:10;s:27:\"TAYLOR-PAPADIMITRIOU, Joyce\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CNREA8\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:88:\"Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:40:\"American Association for Cancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
